Clinical Trials Logo

Diaphragm Issues clinical trials

View clinical trials related to Diaphragm Issues.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06396949 Recruiting - Depression Clinical Trials

The Relationship Between Diaphragm Muscle Thickness and Fibromyalgia

Start date: December 15, 2023
Phase:
Study type: Observational

Fibromyalgia syndrome is characterized by chronic pain, fatigue, sleep problems and functional symptoms. Fatigue, anxiety and depression disorders, poor quality of life, sleep disorders, decreased concentration, and impaired cognitive functions are non-specific pain-related symptoms. Various studies have reported decreased chest expansion, maximal ventilatory volume and maximal expiratory pressure in fibromyalgia patients with widespread body pain. Additionally, dyspnea is a symptom associated with respiratory muscle weakness and is associated with general fatigue. In these individuals, lower data are obtained in daily living activities and general health evaluation surveys. We did not find any study in the literature regarding the relationship between diaphragm thickness and fibromyalgia symptoms. In the light of these data, we aimed to evaluate the thickness of the diaphragm, one of the most important inspiratory muscles, in fibromyalgia patients.

NCT ID: NCT05951114 Recruiting - Neurosurgery Clinical Trials

Post-neurosurgical Respiratory Muscle Dysfunction

Start date: July 1, 2023
Phase:
Study type: Observational

Respiratory muscle dysfunction may contribute to the development of postoperative pulmonary complications. However, it prevalence in patients receiving neurosurgery is largely unknown. Therefore, in present study, respiratory muscle function (measured by the ultrasound) and their correlation with the post-operative pulmonary complications will be analyzed.

NCT ID: NCT05883163 Recruiting - Diaphragm Issues Clinical Trials

STIMIT Activator 1 IDE Pivotal Study

Start date: November 7, 2023
Phase: N/A
Study type: Interventional

The study is a prospective, multi-center, randomized, controlled study using adaptive design to assess the evidence of safety and performance of the STIMIT Activator 1 System in the treatment of patients who have been mechanically ventilated for up to 48 hours and are predicted to require additional minimum 48 hours of mechanical ventilation or longer (adding up to MV time approximately 96 hours or longer).

NCT ID: NCT05211661 Recruiting - Respiratory Failure Clinical Trials

Diaphragm Atrophy and Dysfunction in Mechanical Ventilation

DAM
Start date: October 10, 2022
Phase:
Study type: Observational

The gold standard of twitch transdiaphragmatic pressure recordings would ultimately clear the fog around the rate of development of Ventilator induced Diaphragm Dysfunction (VIDD) in mechanically ventilated patients over time. Through measurements made even after mechanical ventilation (MV) it could be clarified to what extent patients recover from VIDD. Paired with cortical stimulation and electromyographic recordings of diaphragm muscle potentials, it could be explored to what extent decreased diaphragm excitability due to long term MV contributes to VIDD on the level of motor cortex. Against that background the present project aims at determining the rate of decline in diaphragm function, strength and control in patients undergoing MV (including measurements after extubation).

NCT ID: NCT04962568 Recruiting - Diaphragm Issues Clinical Trials

Ultrasonographic Evaluation of the Diaphragm During NHF Versus NIV Use in Respiratory Failure

SENNI
Start date: July 7, 2021
Phase: N/A
Study type: Interventional

This study will describe influence of NHF or NIV to different ultrasonographic parameters of the diaphragm. Therefor subjects will be randomized to the sequence NHF and than NIV or NIV and than NHF. In all subjects same parameters will be evaluated.